News & Events about Azenta Inc.
SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN),a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023. Dr. Nova succeeds Brian Birk, who has ...
Azenta to participate in the 25th Annual Needham Growth Conference Azenta to participate in the 25th Annual Needham Growth Conference PR Newswire BURLINGTON, Mass., Jan. 5, 2023 BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will...
Azenta Announces $500 Million Accelerated Share Repurchase Agreement Azenta Announces $500 Million Accelerated Share Repurchase Agreement PR Newswire CHELMSFORD, Mass., Nov. 23, 2022 CHELMSFORD, Mass., Nov. 23, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered...
Ticker Report
3 months ago
SG Americas Securities LLC acquired a new position in Azenta, Inc. (NASDAQ:AZTA Get Rating) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 24,311 shares of the companys stock, valued at approximately $1,753...
Zacks Investment Research upgraded shares of Azenta (NASDAQ:AZTA Get Rating) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning, Zacks.com reports. According to Zacks, Azenta Inc. is a provider of life sciences solutions. The company ...